Literature DB >> 14206913

PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).

D J FERNBACH.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANTINEOPLASTIC AGENTS; CHILD; DRUG THERAPY; HODGKIN'S DISEASE; LEUKEMIA; NEUROBLASTOMA; SARCOMA, OSTEOGENIC; STATISTICS; TERATOID TUMOR; THROMBOPENIA; TOXICOLOGIC REPORT; UREA

Mesh：

Substances：

Year:  1964        PMID： 14206913

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  1 in total

1.  Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study.

Authors:  Ronald Dubowy; Michael Graham; Nasrollah Hakami; Morris Kletzel; Donald Mahoney; Edward Newman; Yaddanapudi Ravindranath; Bruce Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2008-05       Impact factor: 1.289
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.